Apoptosis-related gene expression can predict the response of ovarian cancer cell lines to treatment with recombinant human TRAIL alone or combined with cisplatin

Braga, Letícia da Conceição; Gonçales, Nikole Gontijo; Furtado, Rafaela de Souza; Andrade, Warne Pedro de; Silva, Luciana Maria; Silva Filho, Agnaldo Lopes da.
Clinics ; 75: e1492, 2020. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1089592

Documentos relacionados

  1. Apoptosis-related gene expression can predict the response of ovarian cancer cell lines to treatment with recombinant human TRAIL alone or combined with cisplatin.
  2. Systematic Identification of Proteins Binding with Cisplatin in Blood by Affinity Chromatography and a Four-Dimensional Proteomic Method.
  3. [Expert Recommendation for the Implementation of Hyperthermic Intrathoracic Chemotherapy (HITOC) in Germany].
  4. Metallodrug-protein interaction probed by synchrotron terahertz and neutron scattering spectroscopy.
  5. ML216-Induced BLM Helicase Inhibition Sensitizes PCa Cells to the DNA-Crosslinking Agent Cisplatin.
  6. Cisplatin and progesterone separate and combined action on rat brain nuclear phospholipids content.
  7. Astragaloside II enhanced sensitivity of ovarian cancer cells to cisplatin via triggering apoptosis and autophagy.
  8. Effects of Nutraceuticals on Cisplatin-Induced Cytotoxicity in HEI-OC1 Cells.
  9. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo.
  10. New Advancements in Cisplatin-Based Treatments.